Abstract:Abstract Background Cervical cancer is one of the most common cancers in women and could be prevented by human papilloma virus (HPV) vaccination. Cervarix, the first available HPV vaccine, has been widely administrated to Chinese women, while little was known about its effect on the prevention and control for HPV related diseases in China. The study aims to assess the impact of Cervarix on HPV infection and cervical related diseases in real world. Methods This is a prospective, multi-age birth cohort study to investigate the incidence and continuous status of HPV infection, and relevant cervical diseases by exposure status (with Cervarix vaccination history or without any HPV vaccination history). It is planned to recruit 12,118 eligible women at age of 9 to 45 years from vaccination clinics or hospital outpatient clinics, and then follow up them for three years. The standard questionnaire will be used to collect information such as demographic characteristics, menstruation and obstetrical histories, history of sexual behavior, personal behavior history, history of disease and pathogen infection, medication history, and family history at baseline. After three years, the changes of these behaviors will be investigated again, and other related health status information will be retrieved from the electronic health records during the follow-up period. If available physically and legally, the cervical cancer screening will be performed, including type-specific HPV deoxyribonucleic acid (DNA) polymerase chain reaction (PCR) testing and contingent thinprep cytologic test (TCT) and colposcopy. The free cervical cancer screening will be captured and uploaded timely to the Yinzhou Regional Health Information Platform (YRHIP); therefore, the long-term outcomes of participants will be monitored. Discussion This prospective cohort study will assess the impact of HPV vaccine on HPV infection and related cervical diseases in women aged 9–45 years, which makes up for the lack of evidence in Chinese women. The results of this study will provide support for understanding the impact of HPV vaccination in China, and make a contribution to increasing HPV vaccination and cervical cancer screening coverage in China. Trial registration This study has been retrospectively registered on clinicaltrials.gov (NCT05341284) on April 22, 2022.

A systematic review of phase Ⅱ/m trials of preventive HIV vaccine

Strategy for the development of AIDS vaccine against Chinese HIV-1 subtypes and recent progress——the introduction of the project supported by the National Science and Technology Key Project on Major Infectious Diseases

Systematic review of HIV prevention interventions in China: a health communication perspective

Approaches to the Research in HIV Vaccine

Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects

Progresses of HIV/AIDS Vaccine Research

HIV Vaccines and Cure

HIV/AIDS vaccine development: are we walking out from the dark?

Incidence And Associated Factors Of Hiv Drug Resistance In Chinese Hiv-Infected Patients Receiving Antiretroviral Treatment

Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis.

Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS): Protocol of a Prospective Cohort

Willingness to Participate in HIV Therapeutic Vaccine Trials among HIV-infected Patients on ART in China.

Interventions to improve the HIV continuum of care in China

Cost-Effectiveness of Pre-exposure Prophylaxis among Men Who Have Sex with Men in China: A Systematic Review

HIV-1 Diversity, Drug-Resistant Mutations, and Viral Evolution among High-Risk Individuals in Phase II HIV Vaccine Trial Sites in Southern China.

Evolution of HIV/AIDS Prevention and Control Policies in China: A Grounded Theory Approach

Treatment for HIV Prevention Study in Southwestern Areas of China.

Clinical epidemiology of HIV/AIDS in China from 2004-2011.

Prevention of mother-to-child HIV transmission cascade in China: a systematic review and meta-analysis.

HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence

Effectiveness of eHealth interventions for HIV prevention, testing and management: An umbrella review